Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Distribution of Trigger Points in Patient Who Have Myofascial Pain Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03962556
Recruitment Status : Recruiting
First Posted : May 24, 2019
Last Update Posted : May 24, 2019
Sponsor:
Information provided by (Responsible Party):
Funda Bastürk, Necmettin Erbakan University

Brief Summary:

Myofascial pain alone covers 45.3% of the diagnosis of TMJ. It is defined as palpation sensitivity and regional muscle pain. Clinically muscle pain connects to myofascial trigger points.These trigger points are hypersensitive points located in a tense band of the skeletal muscle, which can be described, causing provoked or spontaneous pain. They are divided into two as active and latent. Those who cause spontaneous pain are active, and those who provoke pain are considered latent.Spasm in the chewing muscles with myofascial pain reduces the patient's pain threshold and quality of life.

Therefore, patients with spasm and TMJ pain in the masticatory muscles should be examined for head and neck muscles, the presence of myofascial trigger points should be determined and the head and neck muscles should be included in physical therapy.

The aim of this study was to determine the presence of myofascial trigger points in patients presenting with pain in the masticatory muscles and TMJ region, and to determine the relationship between the presence of trigger point and the degree of pain.


Condition or disease Intervention/treatment
Myofascial Pain Other: bimanual palpation

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Distribution of Trigger Points in Patient Who Have Myofascial Pain Disorder
Actual Study Start Date : December 15, 2018
Estimated Primary Completion Date : July 15, 2019
Estimated Study Completion Date : October 15, 2019

Group/Cohort Intervention/treatment
Non-Trigger Point Other: bimanual palpation
bimanual palpation....i..

Trigger Point Other: bimanual palpation
bimanual palpation....i..




Primary Outcome Measures :
  1. masticatory and cervical muscles examination for determining trigger points [ Time Frame: first day visit ]
    detecting the trigger point (yes or no), determining the number of trigger points and determining the region on the muscle

  2. visual analog scale for pain (VAS) [ Time Frame: first day visit ]
    scale to find pain amount , pain scores from 0 to 10 will be taken from patients and higher scores indicate worse pain,all of patient's mean pain score to be determined.


Secondary Outcome Measures :
  1. prevalence of trigger points in facial pain disorder patients [ Time Frame: 1 year ]
    to compare pain scores of patients with and without trigger point,the distribution of trigger points on the masticatory and cervical muscles



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Will be conducted in volunteers who applied to our clinic with complaint of TMJ
Criteria

Inclusion Criteria:

  • Will be conducted in volunteers who applied to our clinic with complaint of TMJ

Exclusion Criteria:

  • Diagnosed rheumatoid diseases and fibromyalgia.
  • Psychiatric drug users.
  • Patients who use muscle relaxants.
  • TME pathology

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03962556


Contacts
Layout table for location contacts
Contact: Funda Basturk +905531906023 dtfunda.basturk@gmail.com

Locations
Layout table for location information
Turkey
Necmettin Erbakan University/Dentistry Faculty Recruiting
Konya, Turkey
Contact: Kubilay Işık         
Sponsors and Collaborators
Necmettin Erbakan University
Investigators
Layout table for investigator information
Study Chair: Kubilay Işık Necmettin Erbakan University/Dentistry Faculty
Study Director: Dilek Menziletoğlu Necmettin Erbakan University/Dentistry Faculty
Principal Investigator: Funda Basturk Necmettin Erbakan University/Dentistry Faculty

Layout table for additonal information
Responsible Party: Funda Bastürk, Research assistant in Oral and Maxillofacial surgery, Necmettin Erbakan University
ClinicalTrials.gov Identifier: NCT03962556     History of Changes
Other Study ID Numbers: NecmettinEU1
First Posted: May 24, 2019    Key Record Dates
Last Update Posted: May 24, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Funda Bastürk, Necmettin Erbakan University:
trigger point,myofacial pain

Additional relevant MeSH terms:
Layout table for MeSH terms
Myofascial Pain Syndromes
Somatoform Disorders
Muscular Diseases
Musculoskeletal Diseases
Mental Disorders